23585716|t|Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline.
23585716|a|Present anti-PD and -AD drugs have limited symptomatic activity and devoid of neuroprotective and neurorestorative property that is needed for disease modifying action. The complex pathology of PD and AD led us to develop several multi-target neuroprotective and neurorestorative drugs with several CNS targets with the ability for possible disease modifying activity. Employing the pharmacophore of our anti-parkinson drug rasagiline (Azilect, N-propagrgyl-1-R-aminoindan), we have developed a series of novel multi-functional neuroprotective drugs (A) [TV-3326 (N-propargyl-3R-aminoindan-5yl)-ethyl methylcarbamate)], with both cholinesterase-butyrylesterase and brain selective monoamine-oxidase (MAO) A/B inhibitory activities and (B) the iron chelator-radical scavenging-brain selective monoamine oxidase (MAO) A/B inhibitor and M30 possessing the neuroprotective and neurorescuing propargyl moiety of rasagiline, as potential treatment of AD, DLB and PD with dementia. Another series of multi-target drugs (M30, HLA-20 series) which are brain permeable iron chelators and potent selective brain MAO inhibitors were also developed. These series of drugs have the ability of regulating and processing amyloid precursor protein (APP) since APP and alpha-synuclein are metaloproteins (iron-regulated proteins), with an iron responsive element 5"UTR mRNA similar to transferring and ferritin. Ladostigil inhibits brain acetyl and butyrylcholinesterase in rats after oral doses. After chronic but not acute treatment, it inhibits MAO-A and -B in the brain. Ladostigil acts like an anti-depressant in the forced swim test in rats, indicating a potential for anti-depressant activity. Ladostigil prevents the destruction of nigrostriatal neurons induced by infusion of neurotoxin MPTP in mice. The propargylamine moiety of ladostigil confers neuroprotective activity against cytotoxicity induced by ischemia and peroxynitrite in cultured neuronal cells. The multi-target iron chelator M30 has all the properties of ladostigil and similar neuroprotective activity to ladostigil, but is not a ChE inhibitor. M30 has a neurorestorative activity in post-lesion of nigrostriatal dopamine neurons in MPTP, lacatcystin and 6-hydroxydopamine animal models of PD. The neurorestorative activity is related to the ability of the drug to activate hypoxia inducing factor (HIF) which induces the production of such neurotrophins as brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF) and erythropoietin as well as glia-derived neurotrophic factor (GDNF). The unique multiple actions of ladostigil and M30 make the potentially useful drugs for the treatment of dementia with Parkinsonian-like symptoms and depression.
23585716	55	89	Parkinson and anti-Alzheimer drugs	Disease	MESH:D010302
23585716	90	100	ladostigil	Chemical	MESH:C423264
23585716	105	108	m30	Chemical	-
23585716	122	132	rasagiline	Chemical	MESH:C031967
23585716	147	149	PD	Disease	MESH:D010300
23585716	155	157	AD	Disease	MESH:D000544
23585716	328	330	PD	Disease	MESH:D010300
23585716	335	337	AD	Disease	MESH:D000544
23585716	543	552	parkinson	Disease	MESH:D010302
23585716	558	568	rasagiline	Chemical	MESH:C031967
23585716	570	577	Azilect	Chemical	MESH:C031967
23585716	579	606	N-propagrgyl-1-R-aminoindan	Chemical	-
23585716	689	696	TV-3326	Chemical	MESH:C423264
23585716	698	750	N-propargyl-3R-aminoindan-5yl)-ethyl methylcarbamate	Chemical	MESH:C423264
23585716	815	842	monoamine-oxidase (MAO) A/B	Gene	17161;109731
23585716	877	881	iron	Chemical	MESH:D007501
23585716	945	953	MAO) A/B	Gene	17161;109731
23585716	968	971	M30	Chemical	-
23585716	1021	1030	propargyl	Chemical	-
23585716	1041	1051	rasagiline	Chemical	MESH:C031967
23585716	1079	1081	AD	Disease	MESH:D000544
23585716	1083	1086	DLB	Disease	MESH:D020961
23585716	1091	1093	PD	Disease	MESH:D010300
23585716	1099	1107	dementia	Disease	MESH:D003704
23585716	1147	1150	M30	Chemical	-
23585716	1193	1207	iron chelators	Chemical	-
23585716	1339	1364	amyloid precursor protein	Gene	54226
23585716	1385	1400	alpha-synuclein	Gene	29219
23585716	1455	1459	iron	Chemical	MESH:D007501
23585716	1528	1538	Ladostigil	Chemical	MESH:C423264
23585716	1554	1586	acetyl and butyrylcholinesterase	Gene	65036
23585716	1590	1594	rats	Species	10116
23585716	1664	1676	MAO-A and -B	Gene	29253;25750
23585716	1691	1701	Ladostigil	Chemical	MESH:C423264
23585716	1719	1730	-depressant	Chemical	-
23585716	1758	1762	rats	Species	10116
23585716	1817	1827	Ladostigil	Chemical	MESH:C423264
23585716	1912	1916	MPTP	Chemical	MESH:D015632
23585716	1920	1924	mice	Species	10090
23585716	1930	1944	propargylamine	Chemical	MESH:C009054
23585716	1955	1965	ladostigil	Chemical	MESH:C423264
23585716	2007	2019	cytotoxicity	Disease	MESH:D064420
23585716	2031	2039	ischemia	Disease	MESH:D007511
23585716	2044	2057	peroxynitrite	Chemical	MESH:D030421
23585716	2103	2107	iron	Chemical	MESH:D007501
23585716	2117	2120	M30	Chemical	-
23585716	2147	2157	ladostigil	Chemical	MESH:C423264
23585716	2198	2208	ladostigil	Chemical	MESH:C423264
23585716	2238	2241	M30	Chemical	-
23585716	2306	2314	dopamine	Chemical	MESH:D004298
23585716	2326	2330	MPTP	Chemical	MESH:D015632
23585716	2332	2343	lacatcystin	Chemical	-
23585716	2348	2365	6-hydroxydopamine	Chemical	MESH:D016627
23585716	2383	2385	PD	Disease	MESH:D010300
23585716	2551	2584	brain-derived neurotrophic factor	Gene	24225
23585716	2586	2590	BDNF	Gene	24225
23585716	2593	2627	vascular endothelial growth factor	Gene	83785
23585716	2629	2633	VEGF	Gene	83785
23585716	2639	2653	erythropoietin	Gene	24335
23585716	2665	2697	glia-derived neurotrophic factor	Gene	25453
23585716	2699	2703	GDNF	Gene	25453
23585716	2737	2747	ladostigil	Chemical	MESH:C423264
23585716	2752	2755	M30	Chemical	-
23585716	2811	2819	dementia	Disease	MESH:D003704
23585716	2825	2851	Parkinsonian-like symptoms	Disease	MESH:D010302
23585716	2856	2866	depression	Disease	MESH:D003866
23585716	Negative_Correlation	MESH:C423264	29253
23585716	Association	24225	83785
23585716	Association	MESH:D004298	MESH:D003866
23585716	Association	MESH:C031967	MESH:D003866
23585716	Negative_Correlation	MESH:C423264	MESH:D003866
23585716	Association	MESH:D003866	24225
23585716	Negative_Correlation	MESH:C423264	MESH:D010300
23585716	Negative_Correlation	MESH:C031967	MESH:D003704
23585716	Negative_Correlation	MESH:C423264	MESH:D000544
23585716	Association	24335	25453
23585716	Negative_Correlation	MESH:C031967	MESH:D020961
23585716	Association	24225	24335
23585716	Negative_Correlation	MESH:C423264	MESH:D010302
23585716	Negative_Correlation	MESH:C423264	MESH:D015632
23585716	Association	MESH:D004298	24335
23585716	Negative_Correlation	MESH:C423264	65036
23585716	Negative_Correlation	MESH:C009054	MESH:D064420
23585716	Negative_Correlation	MESH:C031967	MESH:D010300
23585716	Association	MESH:D003866	83785
23585716	Negative_Correlation	MESH:C031967	MESH:D010302
23585716	Association	MESH:D004298	83785
23585716	Association	MESH:D016627	25453
23585716	Association	MESH:D004298	24225
23585716	Negative_Correlation	MESH:C009054	MESH:D030421
23585716	Association	MESH:D016627	24335
23585716	Association	MESH:D007501	29219
23585716	Association	MESH:C423264	24225
23585716	Association	MESH:D016627	MESH:D003866
23585716	Negative_Correlation	MESH:C423264	25750
23585716	Association	MESH:D004298	MESH:D016627
23585716	Association	24335	83785
23585716	Association	25453	83785
23585716	Positive_Correlation	MESH:D030421	MESH:D064420
23585716	Association	MESH:D016627	83785
23585716	Negative_Correlation	MESH:C009054	MESH:D007511
23585716	Association	MESH:D016627	24225
23585716	Association	24225	25453
23585716	Association	MESH:D004298	25453
23585716	Association	MESH:D003866	24335
23585716	Association	MESH:D003866	25453
23585716	Negative_Correlation	MESH:C031967	MESH:D000544
23585716	Negative_Correlation	MESH:C423264	MESH:D007511

